Cost Effectiveness of Sacubitril/Valsartan Versus Angiotensin-Converting-Enzyme Inhibitor For The Treatment of Heart Failure From Public Health Perspective in Chile
Abstract
Authors
R Rojas C Balmaceda C Vargas MA Espinoza